Aledade
<UNKNOWN>, US · Founded 2014 · Delaware corporation · 12 known investors
Aledade is an accountable care organization (ACO) partner that works with primary care organizations to improve patient outcomes and healthcare quality. The company operates as a public benefit corporation focused on supporting member primary care organizations and their patients.
Founders & leadership
BS
Bijan SalehizadehCo-founder
RK
Robert KocherDirector
FM
Farzad MostashariExecutive Officer, Director
Investors · 12
Activate Venture PartnersBethlehem · $5M
ARCH Venture PartnersChicago · $50K – $250M
Echo Health VenturesDurham
GV (Google Ventures)Mountain View · $250K – $50M
Intrepid Growth PartnersToronto
IVP (Institutional Venture Partners)San Francisco · $15M – $75M
McKesson VenturesSan Francisco
OMERS Private Equity Inc.Toronto
Fidelity InvestmentsreportedBoston
Lightspeed Venture PartnersreportedMenlo Park · $1.7M – $87M
VenrockreportedPalo Alto · $500K – $10M
Venrock AssociatesreportedPalo Alto
Reported raises · per SEC filings
Form D private placements▶$260MraisedJun 2023 · 11 investors · Other TechnologyRule 506(b)
▶$260MraisedJun 2023 · 11 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Phuong PhillipsExecutive Officer
- Michelle RyanDirector
- John DoyleExecutive Officer
- Paul HennessyDirector
- Farzad MostashariExecutive Officer, Director
- David BlumenthalDirector
- Robert KocherDirector
- Phyllis YaleDirector
- Julie SunderlandDirector
- Bijan SalehizadehDirector
- Matthew KendallExecutive Officer
- Offering amount
- $260M
- Amount sold
- $260M
- First sale
- Jun 2023
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$122.3MraisedJun 2022 · 20 investors · Other TechnologyRule 506(b)
▶$122.3MraisedJun 2022 · 20 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Farzad MostashariExecutive Officer, Director
- Kendall MatExecutive Officer
- Bijan SalehizadehDirector
- John DoyleExecutive Officer
- Julie SunderlandDirector
- Phyllis YaleDirector
- Michelle RyanDirector
- Robert KocherDirector
- Offering amount
- $122.3M
- Amount sold
- $122.3M
- First sale
- May 2022
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$100MraisedJan 2021 · 10 investors · Other Health CareRule 506(b)
▶$100MraisedJan 2021 · 10 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Mat KendallExecutive Officer
- James ManziDirector
- Julie SunderlandDirector
- Farzad MostashariExecutive Officer, Director
- Robert KocherDirector
- Offering amount
- $100M
- Amount sold
- $100M
- First sale
- Jan 2021
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$64.4MraisedApr 2020 · 11 investors · Other Health CareRule 506(b)
▶$64.4MraisedApr 2020 · 11 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Farzad MostashariExecutive Officer, Director
- Charles ColliganExecutive Officer
- James ManziDirector
- Patrick ConwayDirector
- Julie SunderlandDirector
- Robert KocherDirector
- Offering amount
- $77.2M
- Amount sold
- $64.4M
- First sale
- Apr 2020
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$56.1MraisedJan 2019 · 17 investors · Other Health CareRule 506(b)
▶$56.1MraisedJan 2019 · 17 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Julie SunderlandDirector
- Farzad MostashariExecutive Officer, Director
- Charles ColliganExecutive Officer
- Robert KocherDirector
- James ManziDirector
- Offering amount
- $56.1M
- Amount sold
- $56.1M
- First sale
- Dec 2017
- Incorporated
- Corporation, Delaware, 2014
- Federal exemptions
- 06b
▶$40.2MraisedMar 2017 · 11 investors · Other Health CareRule 506(b)
▶$40.2MraisedMar 2017 · 11 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Robert KocherDirector
- Mark McClellanDirector
- Stephen B. ThauExecutive Officer
- Farzad MostashariExecutive Officer, Director
- Julie SunderlandDirector
- Offering amount
- $40.2M
- Amount sold
- $40.2M
- First sale
- Dec 2016
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$15MraisedJun 2015 · 7 investors · Other Health CareRule 506(b)
▶$15MraisedJun 2015 · 7 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Robert KocherDirector
- Farzad MostashariExecutive Officer, Director
- Offering amount
- $30M
- Amount sold
- $15M
- First sale
- May 2015
- Incorporated
- Corporation, Delaware, 2014
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
- Aledade closes $500M credit facility to fuel value-based care expansionfiercehealthcare.com · 2025
- Buy Aledade stock and other Pre-IPO shares on UpMarketupmarket.co · 2025
- The Week’s 10 Biggest Funding Rounds: Aledade Rolls Up Huge Round, KoBold Metal Mines Big Moneynews.crunchbase.com · 2023
- Aledade Secures $260 Million Series F Financing Round to Expand and Enhance Services for its Nationwide Network of Primary Care Practicesaledade.com · 2023